Is Hims & Hers or Mochi Health better for weight loss?

Neither has a trial figure recorded here that could answer it, so this page does not pick one. What it can compare is commitment and what sits on each one's public record — all from stored figures with the date each was read.

Which is cheaper, Hims & Hers or Mochi Health?

Hims & Hers and Mochi Health publish no all-in monthly price that could be verified, so this page carries no comparison rather than an estimate — and an unpublished price is itself worth weighing.

Can you switch between Hims & Hers and Mochi Health?

Yes, but the product changes with the service: Hims & Hers offers branded semaglutide; Mochi Health, compounded semaglutide and tirzepatide. Both prescribe through their own clinicians, so the one you move to writes its own prescription. Both are month to month.

← All providers and medications

Hims & Hers vs Mochi Health

Verdict

Neither comes out ahead on the axes compared here: Hims & Hers wins on approved product or compounded copy and Mochi Health on regulatory and complaint risk. Hims & Hers scores higher on the published halfrx formula, 4.5 against 2.9; the formula takes in more than this table does.

Computed from the stored fields, so it moves when a price does. Nothing here is written by hand or by a model.

Hims & Hers or Mochi Health: what can be compared?

Neither publishes an all-in monthly price, so there is no figure to compare on, and any single number either one is quoted at elsewhere was assembled by somebody else. What can be compared is everything below: the commitment, the medication, the record and the terms. Every axis below is computed from stored fields rather than written by hand, so the comparison moves when a price does. Both were last checked on 2026-09-13. Flags recorded here: Hims & Hers — FTC lawsuit, state action, cancellation complaints, FDA warning letter; Mochi Health — manufacturer lawsuit, cancellation complaints. Hims & Hers supplies an FDA-approved product and Mochi Health a compounded preparation made under the pharmacy-compounding exemption, which is a legal status rather than a quality claim. The published formula scores them 4.5 and 2.9 out of 10, arithmetic over the same stored fields rather than an editor's preference.

Head to head

Hims & Hers against Mochi Health, one row per axis, with the side that wins each axis marked.
What decides it	Hims & Hers price unverified	Mochi Health price unverified
Entry priceNot comparable — Hims & Hers and Mochi Health publish no verified all-in price.	not comparable	not comparable
CommitmentBoth are month to month.	tied	tied
Regulatory and complaint riskHims & Hers: 4 serious flags. Mochi Health: 2 serious flags.	—	✓ better here
Approved product or compounded copyHims & Hers supplies an FDA-approved product; Mochi Health supplies a compounded preparation, which the FDA does not review for safety, efficacy or quality and which can stop shipping if its pharmacy is enjoined.	✓ better here	—

Go to Hims & Hers ↗Go to Mochi Health ↗

What separates these two, price aside

They share semaglutide but not the product's legal status: Hims & Hers offers the FDA-approved product and Mochi Health a compounded preparation, so they are not the same purchase. Mochi Health also offers tirzepatide.

Provider

Hims & Hers

4.5

Price unverified

checked 2026-09-13 — the seller publishes no all-in price

FTC lawsuitState actionCancellation complaintsIntro price expiredFDA warning letter

Provider

Mochi Health

2.9

Price unverified

checked 2026-09-13 — the seller publishes no all-in price

Compounding legal riskManufacturer lawsuitCancellation complaintsMaintenance price unpublished

Hims & Hers

Pros

+Its iPhone app carries 94,685 ratings on Apple's listing, second only to PlushCare's among the sellers' own care apps — a measure of how many people have used it, not of how well it works.[5]
+Offers insurance support alongside the cash program.[3]

Cons

−On 29 July 2026 the FTC, joined by Utah and California, sued Hims alleging it enrolled consumers in recurring prescription subscriptions without express informed consent, obscured recurring refill charges, and made cancellation unnecessarily difficult.[6]
−The same complaint alleges Hims misrepresented how it handled sensitive health information and shared it with advertising platforms.[6]
−Hims never prices the membership and the medication together: $39 for a first month, $149 a month after, and the medication billed separately — so no monthly total is published to hold them to.
−Refunds are pro-rated case-by-case rather than by a published rule.[4]

Sources

Mochi Health

Pros

+Month-to-month cancellation, no minimum term.[2]
+Strongest insurance-support workflow among compounded providers for patients who later switch to branded Wegovy or Zepbound.[1]
+Prepaying lowers the membership: $69 a month on a 3-month plan, $59 on a 6-month plan and $49 on a 12-month plan, against $79 month to month.[5]

Cons

−More than 1,200 complaints on file with the Better Business Bureau, concentrated on cancellation and refund handling.[3]
−Its published terms state that cancellation requests sent by email are not valid — you must use their specified channel or keep being billed.[2]
−Its former compounding pharmacy, Aequita of Kirkland, Washington, was ordered to stop compounding by the state's Pharmacy Commission in March 2025, for letting untrained, unsupervised staff do sterile compounding.[8]
−Two manufacturer lawsuits are open in federal court in California: Eli Lilly's, which the judge let proceed in part on 8 September 2026, and Novo Nordisk's, now in discovery.[6]
−Not BBB-accredited.[3]
−The $49 a month is the 12-month plan, paid up front: $548 due today for the first 12 months, then $588 a year. Only the $79 plan is month to month.[5]

Sources

Comparisons are computed from the fields on each card, not written by hand or by a model, so they change when the data does. Information only, not medical advice. halfrx may earn a commission from some links, which never changes what a comparison says.

Everything on Hims & Hers

Everything on Mochi Health

The registers and documents behind both sides

Two cards compared on the same checks. These are the registers those checks were run against, and the FDA's own pages where either side is a compounded product.

Warning letters, U.S. Food and Drug Administration — The register searched for every seller on this site. A letter found here is linked from the seller's page to the original.
Cases and proceedings, Federal Trade Commission — The register searched for advertising and billing actions against a seller.
Compounding and the FDA: questions and answers — What a compounded drug is, and what the FDA does and does not review before it is sold.
Medications containing semaglutide marketed for type 2 diabetes or weight loss, FDA — The FDA's own notice on compounded semaglutide and what it has not evaluated.

Hims & Hers against Mochi Health, answered

Is Hims & Hers or Mochi Health better for weight loss?: Neither has a trial figure recorded here that could answer it, so this page does not pick one. What it can compare is commitment and what sits on each one's public record — all from stored figures with the date each was read.
Which is cheaper, Hims & Hers or Mochi Health?: Hims & Hers and Mochi Health publish no all-in monthly price that could be verified, so this page carries no comparison rather than an estimate — and an unpublished price is itself worth weighing.
Can you switch between Hims & Hers and Mochi Health?: Yes, but the product changes with the service: Hims & Hers offers branded semaglutide; Mochi Health, compounded semaglutide and tirzepatide. Both prescribe through their own clinicians, so the one you move to writes its own prescription. Both are month to month.